GLPBio

DNA Damage/DNA Repair

Research Areas

Products Related to DNA Damage/DNA Repair(1968)

  • GC74226 structure
    GC74226Biotin-PEG3-benzophenone
    CAS: 756525-96-9
    Purity: >99.00%

    Biotin-PEG3-benzophenone는 바이오틴으로 표기된 벤조페논이다.

  • GC74250 structure
    GC74250Thymidine-13C10,15N2
    CAS: 1821188-00-4
    Purity: >99.00%

    Thymidine-13C10,15N2는 13C와 15N이 Tmidine으로 표기되어 있습니다.

  • GC74261 structure
    GC74261(R)-(+)-O-Demethylbuchenavianine
    CAS: 1364123-68-1
    Purity: >98.00%

    (R)-(+)-O-Demethylbuchenavianine 는 세포 주기 단백질 의존성 효소 CDK의 억제제입니다.

  • GC74262 structure
    GC74262(S)-(-)-O-Demethylbuchenavianine
    CAS: 91147-18-1

    (S)-(-)-O-Demethylbuchenavianine (화합물 (S) - (‐) - 1) 은 플라보노이드의 일종이다.

  • GC74316 structure
    GC74316ATR kinase substrate peptide
    Purity: >99.00%

    ATR kinase substrate peptide (화합물 45)는 ATR (Ataxia Telangiectasia and Rad3 related) protein kinase (Ki=6 nM)의 강력하고 선택적인 억제제이다.

  • GC74324 structure
    GC74324Cdk5i peptide
    CAS: 2298317-00-5
    Purity: >99.00%

    Cdk5i peptide는 Cdk5에서 유래한 12개 아미노산 펩타이드 조각이다.

  • GC74652 structure
    GC74652Exatecan Intermediate 2 hydrochloride
    CAS: 2437603-23-9
    Purity: >99.00%

    Exatecan Intermediate 2 hydrochloride (화합물 B) 는 Exatecan (DX-8951) 의 중간체입니다.

  • GC74653 structure
    GC74653Exatecan Intermediate 4
    CAS: 2436720-50-0

    Exatecan Intermediate 4 (화합물 B)는 엑사테탄 (DX-8951,)의 중간체이다.

  • GC74654 structure
    GC74654Exatecan Intermediate 4 dihydrochloride
    Purity: >99.00%

    Exatecan Intermediate 4 dihydrochloride은 Exatecan(DX-8951)의 중간체입니다.

  • GC74656 structure
    GC74656Topoisomerase IIα-IN-8
    CAS: 1251578-67-2

    Topoisomerase IIα-IN-8 (15) 화합물은 약 한 인간의 DNA topoisomerase 설계 (htIIa) 억제, 462 ±의 IC50 38.0 μ M.

  • GC74684 structure
    GC74684Topoisomerase II inhibitor 14
    CAS: 305343-00-4
    Purity: >99.00%

    Topoisomerase II inhibitor 14 (화합물 2f) 는 토폴로지아제 II의 강력한 억제제로서 항암 활성을 가지고 있다.

  • GC74712 structure
    GC74712N-6-Methyl-2-deoxyadenosine-d3
    CAS: 1354782-02-7
    Purity: >99.00%

    N-6-Methyl-2-deoxyadenosine-d3 는 에테르 표기 N-6 - Metl-2 - 디옥시 아데노신이다.

  • GC74727 structure
    GC74727JSH-009
    CAS: 2247481-08-7

    JSH-009은 새롭고, 매우 선택적인 CDK9억제제로 전사 연장 조절에 중요하다.

  • GC74733 structure
    GC74733Methoxyamine-d3 Hydrochloride
    CAS: 110220-55-8
    Purity: >99.00%

    Methoxyamine-d3 Hydrochloride (O-Metldroxylamine-d3)는 Methoxyamine drochloride로 표기된 중수소이다.

  • GC75685 structure
    GC75685PolQi1
    CAS: 2607139-80-8
    Purity: >98.00%

    PolQi1 is a selective inhibitor targeting the structure domain of DNA polymerase Polθ.

  • GC75826 structure
    GC75826YL-5092
    CAS: 3056857-07-6
    Purity: >98.00%

    YL-5092 is a novel, highly selective inhibitor of YTHDC1 (IC 50 =7.4nM; K D =29.6nM).

  • GC78755 structure
    GC78755ZW-251
    Purity: >98%

    ZW-251 is a glypican-3 ( GPC3 )-targeted antibody-drug conjugate ( ADC ) with topoisomerase-I inhibitory activity.

  • GC78756 structure
    GC78756Mocertatug rezetecan (DAR4)
    CAS: 3042848-25-6
    Purity: >98.00%

    Mocertatug rezetecan (DAR4) (HS-20089 (DAR4); GSK5733584 (DAR4)) is an antibody-drug conjugate ( ADC ) targeting B7-H4, composed of Mocertatug and MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan.

  • GC78757 structure
    GC78757Mocertatug rezetecan (DAR6)
    CAS: 3042848-25-6
    Purity: >98.00%

    Mocertatug rezetecan (DAR6) (HS-20089 (DAR6); GSK5733584 (DAR6)) is an antibody-drug conjugate ( ADC ) targeting B7-H4, composed of Mocertatug and MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan.

  • GC78759 structure
    GC787592-MSP-5-HA-VA-PAB-Exatecan
    CAS: 2878440-72-1
    Purity: >97.50%

    2-MSP-5-HA-Val-Cit-PAB-Exatecan (A-24) is a drug-linker conjugate for ADC.

  • GC78760 structure
    GC787602-MSP(4-OMe)-5-HA-PEG8-VA-Exatecan
    CAS: 3115661-30-5
    Purity: >97.50%

    2-MSP(4-OMe)-5-HA-PEG8-VA-Exatecan is a Drug-linker conjugates for ADC consisting of the ADC Cytotoxin Exatecan and a linker.

  • GC78761 structure
    GC78761BLD1102
    CAS: 3025473-38-2
    Purity: >99.50%

    BLD1102 is a linker-load conjugate ( Drug-Linker Conjugates for ADC ) consisting of a DNA topoisomerase I inhibitor BCPT02 and a protease-cleavable linker.

  • GC78766 structure
    GC78766N-(Mal)-N-(PEG8-Val-Cit-PAB-MMAE)-N-(PEG8-Val-Cit-PAB-Exatecan)
    Purity: >98.00%

    N-(Mal)-N-(PEG8-Val-Cit-PAB-MMAE)-N-(PEG8-Val-Cit-PAB-Exatecan) is a drug-linker conjugate for ADC (Drug-Linker Conjugate for ADC), consisting of a tubulin polymerization inhibitor MMAE and a DNA topoisomerase I inhibitor Exatecan, and an ADC linker composition.

  • GC78767 structure
    GC78767N-(DBCO-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan)
    Purity: >98.00%

    N-(DBCO-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) is a drug-linker conjugate for ADC (Drug-Linker Conjugate for ADC), consisting of a tubulin polymerization inhibitor MMAE and a DNA topoisomerase I inhibitor Exatecan, and an ADC linker composition.